IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
21 hedge funds and large institutions have $3.14M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, reducing their positions, and 2 closing their positions.
Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
–
Closed
2
Calls
$2.24M
Puts
–
Net Calls
+$2.24M
Net Calls Change
+$37K
Top Buyers
Top Sellers
1 |
MP
1
Mangrove Partners
Greenwich,
Connecticut
|
$0 |
2 |
FTCM
2
Fir Tree Capital Management
New York
|
$0 |